TCI Wealth Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$347K Sell
4,434
-112
-2% -$9.04K 0.02% 187
2026
Q1
$394K Sell
4,546
-371
-8% -$35.5K 0.02% 170
2025
Q4
$472K Sell
4,917
-109
-2% -$10.6K 0.03% 151
2025
Q3
$479K Buy
5,026
+772
+18% +$71K 0.03% 152
2025
Q2
$371K Sell
4,254
-516
-11% -$43.8K 0.03% 170
2025
Q1
$429K Sell
4,770
-575
-11% -$51.5K 0.03% 137
2024
Q4
$427K Buy
5,345
+55
+1% +$4.76K 0.04% 139
2024
Q3
$476K Sell
5,290
-326
-6% -$27.4K 0.04% 135
2024
Q2
$442K Sell
5,616
-171
-3% -$14K 0.04% 131
2024
Q1
$504K Buy
5,787
+27
+0.5% +$2.3K 0.05% 120
2023
Q4
$475K Sell
5,760
-178
-3% -$13.6K 0.05% 119
2023
Q3
$465K Buy
5,938
+112
+2% +$9.38K 0.06% 112
2023
Q2
$513K Buy
5,826
+4
+0.1% +$344 0.07% 106
2023
Q1
$469K Buy
5,822
+90
+2% +$7.33K 0.06% 111
2022
Q4
$446K Sell
5,732
-369
-6% -$29.9K 0.06% 108
2022
Q3
$493K Buy
6,101
+303
+5% +$27.2K 0.08% 96
2022
Q2
$520K Sell
5,798
-261
-4% -$26.4K 0.08% 98
2022
Q1
$672K Buy
6,059
+32
+0.5% +$3.38K 0.1% 84
2021
Q4
$624K Sell
6,027
-66
-1% -$7.64K 0.09% 87
2021
Q3
$764K Buy
6,093
+63
+1% +$8.15K 0.12% 82
2021
Q2
$749K Sell
6,030
-480
-7% -$60.3K 0.13% 79
2021
Q1
$769K Sell
6,510
-478
-7% -$56K 0.33% 64
2020
Q4
$819K Buy
6,988
+4
+0.1% +$440 0.37% 61
2020
Q3
$726K Buy
6,984
+468
+7% +$47K 0.29% 65
2020
Q2
$598K Sell
6,516
-920
-12% -$88.2K 0.26% 67
2020
Q1
$671K Buy
7,436
+343
+5% +$36.5K 0.33% 61
2019
Q4
$805K Buy
7,093
+28
+0.4% +$3.07K 0.31% 63
2019
Q3
$767K Buy
7,065
+210
+3% +$21.9K 0.34% 62
2019
Q2
$668K Sell
6,855
-56
-0.8% -$5.11K 0.3% 66
2019
Q1
$629K Sell
6,911
-16
-0.2% -$1.43K 0.28% 73
2018
Q4
$630K Sell
6,927
-28
-0.4% -$2.62K 0.31% 68
2018
Q3
$684K Sell
6,955
-81
-1% -$7.49K 0.29% 68
2018
Q2
$602K Buy
7,036
+105
+2% +$8.77K 0.27% 75
2018
Q1
$556K Sell
6,931
-553
-7% -$45.6K 0.26% 76
2017
Q4
$604K Buy
7,484
+148
+2% +$11.9K 0.27% 76
2017
Q3
$571K Sell
7,336
-17
-0.2% -$1.41K 0.28% 74
2017
Q2
$653K Sell
7,353
-239
-3% -$20.2K 0.33% 67
2017
Q1
$612K Sell
7,592
-2,431
-24% -$190K 0.32% 65
2016
Q4
$714K Buy
10,023
+629
+7% +$49.4K 0.37% 60
2016
Q3
$812K Sell
9,394
-1,043
-10% -$90.9K 0.44% 57
2016
Q2
$906K Sell
10,437
-3,343
-24% -$270K 0.5% 49
2016
Q1
$1.03M Sell
13,780
-227
-2% -$17.1K 0.57% 44
2015
Q4
$1.08M Sell
14,007
-2,207
-14% -$166K 0.6% 42
2015
Q3
$1.08M Sell
16,214
-204
-1% -$15K 0.65% 40
2015
Q2
$1.22M Sell
16,418
-187
-1% -$14.3K 0.7% 37
2015
Q1
$1.29M Sell
16,605
-164
-1% -$12.4K 0.81% 33
2014
Q4
$1.21M Sell
16,769
-510
-3% -$35.4K 0.75% 36
2014
Q3
$1.07M Sell
17,279
-9
-0.1% -$572 0.67% 37
2014
Q2
$1.1M Sell
17,288
-103
-0.6% -$6.26K 0.66% 37
2014
Q1
$1.07M Hold
17,391
0.7% 34
2013
Q4
$998K Sell
17,391
-137
-0.8% -$7.77K 0.63% 36
2013
Q3
$933K Hold
17,528
0.71% 35
2013
Q2
$902K Buy
+17,528
New +$866K 0.68% 36

Other funds holding MDT

TCI Wealth Advisors's MDT Position: Q2 2026 in Review

TCI Wealth Advisors reduced its Medtronic (MDT) stake by 2.5% in Q2 2026, selling an estimated $9.04K and leaving 4,434 shares worth $347K. The position accounts for 0.02% of the portfolio, ranked #187.

TCI Wealth Advisors first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.29M in Q1 2015. 961 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • TCI Wealth Advisors held 4,434 shares of Medtronic worth $347K as of Q2 2026.
  • TCI Wealth Advisors sold 112 Medtronic shares in Q2 2026, an estimated $9.04K.
  • Medtronic made up 0.02% of TCI Wealth Advisors's portfolio in Q2 2026, its #187 holding.
  • TCI Wealth Advisors first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
  • TCI Wealth Advisors's Medtronic position peaked at $1.29M in Q1 2015.
  • 961 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on TCI Wealth Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.